-
1
-
-
4744376173
-
Pathomechanisms and molecular basis of membranous glomerulopathy
-
Kerjaschki D: Pathomechanisms and molecular basis of membranous glomerulopathy. Lancet 364 (9441): 1194-1196, 2004.
-
(2004)
Lancet
, vol.364
, Issue.9441
, pp. 1194-1196
-
-
Kerjaschki, D.1
-
2
-
-
24944570216
-
Th2 cytokines increase and stimulate B cells to produce IgG4 in idiopathic membranous nephropathy
-
Kuroki A, Iyoda M, Shibata T, Sugisaki T: Th2 cytokines increase and stimulate B cells to produce IgG4 in idiopathic membranous nephropathy. Kidney Int 68 (1): 302-310, 2005.
-
(2005)
Kidney Int
, vol.68
, Issue.1
, pp. 302-310
-
-
Kuroki, A.1
Iyoda, M.2
Shibata, T.3
Sugisaki, T.4
-
3
-
-
23944525929
-
Molecular pathomechanisms of membranous nephropathy: from Heymann nephritis to alloimmunization
-
Ronco P, Debiec H: Molecular pathomechanisms of membranous nephropathy: from Heymann nephritis to alloimmunization. J Am Soc Nephrol 16 (5): 1205-1213, 2005.
-
(2005)
J Am Soc Nephrol
, vol.16
, Issue.5
, pp. 1205-1213
-
-
Ronco, P.1
Debiec, H.2
-
4
-
-
0037182728
-
y cols.: Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies
-
Debiec H, Guigonis V, Mougenot B, Decobert F, Haymann JP, Bensman A y cols.: Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 346 (26): 2053-2060, 2002.
-
(2002)
N Engl J Med
, vol.346
, Issue.26
, pp. 2053-2060
-
-
Debiec, H.1
Guigonis, V.2
Mougenot, B.3
Decobert, F.4
Haymann, J.P.5
Bensman, A.6
-
5
-
-
0033868304
-
Membranous glomerulonephritis (MGN)
-
Horl WH, Kerjaschki D: Membranous glomerulonephritis (MGN). J Nephrol 13 (4): 291-316, 2000.
-
(2000)
J Nephrol
, vol.13
, Issue.4
, pp. 291-316
-
-
Horl, W.H.1
Kerjaschki, D.2
-
6
-
-
23944438985
-
Couser WG: Cellular response to injury in membranous nephropathy
-
Nangaku M, Shankland SJ, Couser WG: Cellular response to injury in membranous nephropathy. J Am Soc Nephrol 16 (5): 1195-1204, 2005.
-
(2005)
J Am Soc Nephrol
, vol.16
, Issue.5
, pp. 1195-1204
-
-
Nangaku, M.1
Shankland, S.J.2
-
7
-
-
0032560040
-
The Nephrotic Syndrome
-
Orth SR, Ritz E: The Nephrotic Syndrome. N Engl J Med 338 (17): 1202-1211, 1998.
-
(1998)
N Engl J Med
, vol.338
, Issue.17
, pp. 1202-1211
-
-
Orth, S.R.1
Ritz, E.2
-
8
-
-
0018397339
-
Long-term prognosis of idiopathic membranous glomerulonephritis
-
Noel LH, Zanetti M, Droz D, Barbanel C: Long-term prognosis of idiopathic membranous glomerulonephritis. Am J Med 66: 82-90, 1979.
-
(1979)
Am J Med
, vol.66
, pp. 82-90
-
-
Noel, L.H.1
Zanetti, M.2
Droz, D.3
Barbanel, C.4
-
9
-
-
0021211763
-
The natural history of renal function in untreated idiopathic membranous glomerulonephritis in adults
-
Davison AM, Cameron JS, Kerr DN, Ogg CS, Wilkinson RW: The natural history of renal function in untreated idiopathic membranous glomerulonephritis in adults. Clin Nephrol 22: 61-67, 1984.
-
(1984)
Clin Nephrol
, vol.22
, pp. 61-67
-
-
Davison, A.M.1
Cameron, J.S.2
Kerr, D.N.3
Ogg, C.S.4
Wilkinson, R.W.5
-
10
-
-
0022510592
-
The natural history of membranous nephropathy in the west of Scotland
-
MacTier R, Boulton Jones JM, Payton CD, McLay A: The natural history of membranous nephropathy in the west of Scotland. Q J Med 60: 793-802, 1986.
-
(1986)
Q J Med
, vol.60
, pp. 793-802
-
-
MacTier, R.1
Boulton Jones, J.M.2
Payton, C.D.3
McLay, A.4
-
11
-
-
0023841028
-
y cols.: Idiopathic membranous nephropathy: the natural history of untreated patients
-
Donadio JJV, Torres VE, Velosa JA y cols.: Idiopathic membranous nephropathy: the natural history of untreated patients. Kidney Int 33: 708-715, 1988.
-
(1988)
Kidney Int
, vol.33
, pp. 708-715
-
-
Donadio, J.J.V.1
Torres, V.E.2
Velosa, J.A.3
-
12
-
-
0027314667
-
y cols.: Prognosis of untreated patients with idiopathic membranous nephropathy
-
Schieppati A, Mosconi L, Perna A y cols.: Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med 329: 85-89, 1993.
-
(1993)
N Engl J Med
, vol.329
, pp. 85-89
-
-
Schieppati, A.1
Mosconi, L.2
Perna, A.3
-
13
-
-
0027292315
-
y cols.: Evolución a largo plazo de las glomerulonefritis membranosas idiopáticas no tratadas
-
Mazuecos AM, Praga M, Araque A y cols.: Evolución a largo plazo de las glomerulonefritis membranosas idiopáticas no tratadas. Nefrología 13: 299-305, 1993.
-
(1993)
Nefrología
, vol.13
, pp. 299-305
-
-
Mazuecos, A.M.1
Praga, M.2
Araque, A.3
-
14
-
-
0018629308
-
Collaborative Study of the Adult Idiopathic Nephrotic Syndrome. A controlled study of short-term prednisone treatment in adults with membranous nephropathy
-
Collaborative Study of the Adult Idiopathic Nephrotic Syndrome. A controlled study of short-term prednisone treatment in adults with membranous nephropathy. N Engl J Med 301: 1301-1306, 1979.
-
(1979)
N Engl J Med
, vol.301
, pp. 1301-1306
-
-
-
15
-
-
0024503584
-
A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy
-
Cattran DC, Delmore T, Roscoe J y cols.: A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy. N Engl J Med 320: 210-215, 1989.
-
(1989)
N Engl J Med
, vol.320
, pp. 210-215
-
-
Cattran, D.C.1
Delmore, T.2
Roscoe, J.3
-
16
-
-
0025021278
-
The Medical Research Council trial of short-term high-dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults
-
Cameron JS, Healy MJR, Adu D.: The Medical Research Council trial of short-term high-dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults. Q J Med 74: 133-156, 1990.
-
(1990)
Q J Med
, vol.74
, pp. 133-156
-
-
Cameron, J.S.1
Healy, M.J.R.2
Adu, D.3
-
17
-
-
0028785260
-
A 10-year followup of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy
-
Ponticelli C, Zuchelli P, Passerini P y cols.: A 10-year followup of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int 48: 1600-1604, 1995.
-
(1995)
Kidney Int
, vol.48
, pp. 1600-1604
-
-
Ponticelli, C.1
Zuchelli, P.2
Passerini, P.3
-
18
-
-
0030934029
-
Validation of a predictive model of idiopathic membranous nephropathy: its clinical and research implications
-
Cattran DC, Pei Y, Greenwood CMT, Ponticelli C, Passerini P, Honkanen E.: Validation of a predictive model of idiopathic membranous nephropathy: its clinical and research implications. Kidney Int 51: 901-907, 1997.
-
(1997)
Kidney Int
, vol.51
, pp. 901-907
-
-
Cattran, D.C.1
Pei, Y.2
Greenwood, C.M.T.3
Ponticelli, C.4
Passerini, P.5
Honkanen, E.6
-
19
-
-
28044458976
-
Idiopathic membranous nephropathy: Outline and rationale of a treatment strategy
-
Du Buf-Vereijken PWG, Branten AJW, Wetzels JFM: Idiopathic membranous nephropathy: Outline and rationale of a treatment strategy. Am J Kidney Dis 46: 1012-1029, 2005.
-
(2005)
Am J Kidney Dis
, vol.46
, pp. 1012-1029
-
-
Du Buf-Vereijken, P.W.G.1
Branten, A.J.W.2
Wetzels, J.F.M.3
-
20
-
-
0028890644
-
y cols.: Low-dose angiotensin-converting enzyme inhibitor captopril to reduce proteinuria in adult idiopathic membranous nephropathy: a prospective study of long-term treatment
-
Rostoker G, Ben Maadi A, Remy P y cols.: Low-dose angiotensin-converting enzyme inhibitor captopril to reduce proteinuria in adult idiopathic membranous nephropathy: a prospective study of long-term treatment. Nephrol Dial Transplant 10: 25, 1995.
-
(1995)
Nephrol Dial Transplant
, vol.10
, pp. 25
-
-
Rostoker, G.1
Ben Maadi, A.2
Remy, P.3
-
21
-
-
15844368318
-
y cols.: Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency
-
Maschio G, Alberti D y cols.: Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The New England Journal of Medicine 334: 939-945, 1996.
-
(1996)
The New England Journal of Medicine
, vol.334
, pp. 939-945
-
-
Maschio, G.1
Alberti, D.2
-
22
-
-
0026737608
-
y cols.: Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria
-
Praga M, Hernández E, Montoyo C y cols.: Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria. Am J Kidney Dis 20: 240-248, 1992.
-
(1992)
Am J Kidney Dis
, vol.20
, pp. 240-248
-
-
Praga, M.1
Hernández, E.2
Montoyo, C.3
-
23
-
-
0028998429
-
Are cytotoxic agents beneficial in idiopathic membranous nephropathy? A metaanalysis of the controlled trials
-
Imperiale TF, Goldfarb S, Berns JS: Are cytotoxic agents beneficial in idiopathic membranous nephropathy? A metaanalysis of the controlled trials. J Am Soc Nephrol 5: 1553-1558, 1995.
-
(1995)
J Am Soc Nephrol
, vol.5
, pp. 1553-1558
-
-
Imperiale, T.F.1
Goldfarb, S.2
Berns, J.S.3
-
24
-
-
0029009350
-
A review of therapeutic studies of idiopathic membranous glomerulopathy
-
Hogan SL, Muller KE, Jennette JC, Falk RJ: A review of therapeutic studies of idiopathic membranous glomerulopathy. Am J Kidney Dis 25: 862-875, 1995.
-
(1995)
Am J Kidney Dis
, vol.25
, pp. 862-875
-
-
Hogan, S.L.1
Muller, K.E.2
Jennette, J.C.3
Falk, R.J.4
-
25
-
-
4444235009
-
y cols.: Immunosuppressive treatment for idiopathic membranous nephro-pathy: a systematic review
-
Perna A, StatSci D, Schieppati A, Zamora J y cols.: Immunosuppressive treatment for idiopathic membranous nephro-pathy: a systematic review. Am J Kidney Dis 44: 385-401, 2004.
-
(2004)
Am J Kidney Dis
, vol.44
, pp. 385-401
-
-
Perna, A.1
StatSci, D.2
Schieppati, A.3
Zamora, J.4
-
26
-
-
0024538205
-
y cols.: Arandomized trial of methylprednisone and chlorambucil in idiopathic membranous nephropathy
-
Ponticelli C, Zucchelli P, Passerini P y cols.: Arandomized trial of methylprednisone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 320: 8-13, 1989.
-
(1989)
N Engl J Med
, vol.320
, pp. 8-13
-
-
Ponticelli, C.1
Zucchelli, P.2
Passerini, P.3
-
27
-
-
0026538435
-
Randomized controlled trial of cyclophosphamide, warfarin, and dipyridamole in idiopathic membranous glomerulonephritis
-
Murphy BF, McDonald I, Fairley KF, Kincaid-Smith PS.: Randomized controlled trial of cyclophosphamide, warfarin, and dipyridamole in idiopathic membranous glomerulonephritis. Clin Nephrol 37: 229-234, 1992.
-
(1992)
Clin Nephrol
, vol.37
, pp. 229-234
-
-
Murphy, B.F.1
McDonald, I.2
Fairley, K.F.3
Kincaid-Smith, P.S.4
-
28
-
-
0016345829
-
Controlled trial of cyclophosphamide in idiopathic membranous nephropathy
-
Donadio JV, Holley KE, Anderson CF, Taylor WF: Controlled trial of cyclophosphamide in idiopathic membranous nephropathy. Kidney Int 6: 431-439, 1974.
-
(1974)
Kidney Int
, vol.6
, pp. 431-439
-
-
Donadio, J.V.1
Holley, K.E.2
Anderson, C.F.3
Taylor, W.F.4
-
29
-
-
0017057548
-
Western Canadian Glomerulonephritis Study Group: Controlled trial of azathioprine in the nephrotic syndrome secondary to idiopathic membranous glomerulonephritis
-
Silverberg DS, for theWestern Canadian Glomerulonephritis Study Group: Controlled trial of azathioprine in the nephrotic syndrome secondary to idiopathic membranous glomerulonephritis. CMAJ 115: 1209-1210, 1976.
-
(1976)
CMAJ
, vol.115
, pp. 1209-1210
-
-
Silverberg, D.S.1
-
30
-
-
0027614357
-
Prognosis and management of membranous nephropathy
-
Pahari DK, Das S, Dutta BN, Banerjee D: Prognosis and management of membranous nephropathy. J Assoc Physicians India 41: 350-351, 1993.
-
(1993)
J Assoc Physicians India
, vol.41
, pp. 350-351
-
-
Pahari, D.K.1
Das, S.2
Dutta, B.N.3
Banerjee, D.4
-
31
-
-
0026687712
-
y cols.: Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy
-
Ponticelli C, Zucchelli P, Passerini P y cols.: Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. N Engl J Med 327: 599-603, 1992.
-
(1992)
N Engl J Med
, vol.327
, pp. 599-603
-
-
Ponticelli, C.1
Zucchelli, P.2
Passerini, P.3
-
32
-
-
0028639437
-
y cols.: Methylprednisolone plus chlorambucil as compared with prednisolone alone for the treatment of idiopathic membranous nephropathy. A preliminary study
-
Ahmed S, Rahman M, Alam MR y cols.: Methylprednisolone plus chlorambucil as compared with prednisolone alone for the treatment of idiopathic membranous nephropathy. A preliminary study. Bangladesh Ren J 13: 51-54, 1994.
-
(1994)
Bangladesh Ren J
, vol.13
, pp. 51-54
-
-
Ahmed, S.1
Rahman, M.2
Alam, M.R.3
-
33
-
-
0026549031
-
y cols.: Treatment of progressive membranous glomerulopathy. A randomized trial comparing cyclophosphamide and corticosteroids with corticosteroids alone
-
Falk RJ, Hogan SL, Muller KE y cols.: Treatment of progressive membranous glomerulopathy. A randomized trial comparing cyclophosphamide and corticosteroids with corticosteroids alone. Ann Intern Med 116: 438-445, 1992.
-
(1992)
Ann Intern Med
, vol.116
, pp. 438-445
-
-
Falk, R.J.1
Hogan, S.L.2
Muller, K.E.3
-
34
-
-
0031890912
-
y cols.: A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy
-
Ponticelli C, Altieri P, Scolari F y cols.: A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. J Am Soc Nephrol 9: 444-450, 1998.
-
(1998)
J Am Soc Nephrol
, vol.9
, pp. 444-450
-
-
Ponticelli, C.1
Altieri, P.2
Scolari, F.3
-
35
-
-
0028605933
-
y cols.: Preserving renal function in patients with membranous nephropathy: Daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide
-
Reichert LJ, Huysmans FT, Assman K y cols.: Preserving renal function in patients with membranous nephropathy: Daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide. Ann Intern Med 121: 328-333, 1994.
-
(1994)
Ann Intern Med
, vol.121
, pp. 328-333
-
-
Reichert, L.J.1
Huysmans, F.T.2
Assman, K.3
-
36
-
-
0031954786
-
Oral cyclophosphamide versus chlorambucil in the treatment of patients with membranous nephropathy and renal insufficiency
-
Branten JW, Reichert LJ, Koene AP, Wetzels JF: Oral cyclophosphamide versus chlorambucil in the treatment of patients with membranous nephropathy and renal insufficiency. QJM 91: 359-366, 1998.
-
(1998)
QJM
, vol.91
, pp. 359-366
-
-
Branten, J.W.1
Reichert, L.J.2
Koene, A.P.3
Wetzels, J.F.4
-
37
-
-
0042911409
-
y cols.: Therapy of membranous glomerulonephritis with nephrotic syndrome. 5 Years followup of a prospective, randomised multi-centre study
-
Braun N, Erley C, Benda N y cols.: Therapy of membranous glomerulonephritis with nephrotic syndrome. 5 Years followup of a prospective, randomised multi-centre study. Nephrol Dial Transplant 10: 967 (abstr), 1995.
-
(1995)
Nephrol Dial Transplant
, vol.10
, Issue.ABSTR
, pp. 967
-
-
Braun, N.1
Erley, C.2
Benda, N.3
-
38
-
-
31044441980
-
y cols.: A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy
-
Ponticelli C, Passerini P, Salvadori M y cols.: A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy. Am J Kidney Dis 47 (2): 233-240, 2005.
-
(2005)
Am J Kidney Dis
, vol.47
, Issue.2
, pp. 233-240
-
-
Ponticelli, C.1
Passerini, P.2
Salvadori, M.3
-
39
-
-
0023265179
-
A controlled trial of cyclophosphamide in patients with membranous glomerulonephritis
-
West ML, Jindal KK, Bear RA, Goldstein MB: A controlled trial of cyclophosphamide in patients with membranous glomerulonephritis. Kidney Int 32 (4): 579-84, 1987.
-
(1987)
Kidney Int
, vol.32
, Issue.4
, pp. 579-584
-
-
West, M.L.1
Jindal, K.K.2
Bear, R.A.3
Goldstein, M.B.4
-
40
-
-
0026591798
-
Long-term benefits of therapy with cyclophosphamide and prednisone in patients with membranous glomerulonephritis and impaired renal function
-
Jindal, KK, West, M, Bear, R, Goldstein, M: Long-term benefits of therapy with cyclophosphamide and prednisone in patients with membranous glomerulonephritis and impaired renal function. Am J Kidney Dis 19: 61-67, 1992.
-
(1992)
Am J Kidney Dis
, vol.19
, pp. 61-67
-
-
Jindal, K.K.1
West, M.2
Bear, R.3
Goldstein, M.4
-
41
-
-
0025729424
-
Sustained remission of membranous glomerulonephritis after cyclophosphamide and prednisone
-
Bruns, FJ, Adler, S, Fraley, DS, Segel, DP: Sustained remission of membranous glomerulonephritis after cyclophosphamide and prednisone. Ann Intern Med 114: 725-730, 1991.
-
(1991)
Ann Intern Med
, vol.114
, pp. 725-730
-
-
Bruns, F.J.1
Adler, S.2
Fraley, D.S.3
Segel, D.P.4
-
42
-
-
0027318589
-
Cyclophosphamideprovides no additional benefit to steroid therapy in the treatment of idiopathic membranous nephropathy
-
Alexopoulos E, Sakellariou G, Memmos D, KaramitsosK, Leontsini M, Papadimitriou M: Cyclophosphamideprovides no additional benefit to steroid therapy in the treatment of idiopathic membranous nephropathy. Am J Kidney Dis 21: 497-503, 1993.
-
(1993)
Am J Kidney Dis
, vol.21
, pp. 497-503
-
-
Alexopoulos, E.1
Sakellariou, G.2
Memmos, D.3
Karamitsos, K.4
Leontsini, M.5
Papadimitriou, M.6
-
43
-
-
0028345151
-
Prednisolone and chlorambucil therapy for idiopathic membranous nephropathy with progressive renal failure
-
Warwick, GL, Geddes, CG, Boulton-Jones, JM: Prednisolone and chlorambucil therapy for idiopathic membranous nephropathy with progressive renal failure. Q J Med 87: 223 -229, 1994.
-
(1994)
Q J Med
, vol.87
, pp. 223-229
-
-
Warwick, G.L.1
Geddes, C.G.2
Boulton-Jones, J.M.3
-
44
-
-
0023729887
-
Prednisolone and chlorambucil treatment in idiopathic membranous nephropathy with deteriorating renal function
-
Mathieson PW, Turner AN, Maidment CG, Evans DJ, Rees AJ: Prednisolone and chlorambucil treatment in idiopathic membranous nephropathy with deteriorating renal function. Lancet 2: 869-872, 1988.
-
(1988)
Lancet
, vol.2
, pp. 869-872
-
-
Mathieson, P.W.1
Turner, A.N.2
Maidment, C.G.3
Evans, D.J.4
Rees, A.J.5
-
45
-
-
0028296025
-
Low-dose prednisolone/ chlorambucil therapy in patients with severe membranous glomerulonephritis
-
Brunkhorst R, Wrenger E, Koch KM: Low-dose prednisolone/ chlorambucil therapy in patients with severe membranous glomerulonephritis. Clin Invest 72: 277-282, 1994.
-
(1994)
Clin Invest
, vol.72
, pp. 277-282
-
-
Brunkhorst, R.1
Wrenger, E.2
Koch, K.M.3
-
46
-
-
0031890746
-
Immunosuppression and outcome in idiopathic membranous nephropathy
-
Stirling CM, Simpson K, Boulton-Jones JM: Immunosuppression and outcome in idiopathic membranous nephropathy. Q J Med 9: 159-164, 1998.
-
(1998)
Q J Med
, vol.9
, pp. 159-164
-
-
Stirling, C.M.1
Simpson, K.2
Boulton-Jones, J.M.3
-
47
-
-
2442526450
-
Cytotoxic therapy for membranous nephropathy and renal insufficiency: Improved renal survival but high relapse rate
-
Du Buf-Vereijken, PW, Branten, AJ, Wetzels, JF: Cytotoxic therapy for membranous nephropathy and renal insufficiency: Improved renal survival but high relapse rate. Nephrol Dial Transplant 19: 1142-1148, 2004.
-
(2004)
Nephrol Dial Transplant
, vol.19
, pp. 1142-1148
-
-
Du Buf-Vereijken, P.W.1
Branten, A.J.2
Wetzels, J.F.3
-
48
-
-
0036145351
-
y cols.: Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy
-
Torres, A, Dominguez-Gil, B, Carreno, A y cols.: Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy. Kidney Int 61: 219-227, 2002.
-
(2002)
Kidney Int
, vol.61
, pp. 219-227
-
-
Torres, A.1
Dominguez-Gil, B.2
Carreno, A.3
-
49
-
-
0026468259
-
Shortterm responsiveness of Membranous Glomerulopathy to Cyclosporine
-
Guasch A, Suranyi M, Newton L, Hall BM, Myers BD: Shortterm responsiveness of Membranous Glomerulopathy to Cyclosporine. Am J Kidney Dis 20: 472-481, 1992.
-
(1992)
Am J Kidney Dis
, vol.20
, pp. 472-481
-
-
Guasch, A.1
Suranyi, M.2
Newton, L.3
Hall, B.M.4
Myers, B.D.5
-
50
-
-
0029974552
-
Mechanisms of the antiproteinuric effect of cyclosporine in membranous nephropathy
-
Ambalavanan S, Fauvel JP, Sibley RK, Myers BD: Mechanisms of the antiproteinuric effect of cyclosporine in membranous nephropathy. J Am Soc Nephrol 7: 290-298, 1996.
-
(1996)
J Am Soc Nephrol
, vol.7
, pp. 290-298
-
-
Ambalavanan, S.1
Fauvel, J.P.2
Sibley, R.K.3
Myers, B.D.4
-
51
-
-
0027516549
-
Long-term cyclosporin A therapy for severe idiopathic membranous nephropathy
-
Rostoker G, Belghiti D, Ben Maadi A, Remy P, Lang P, Weil B, Lagrue G: Long-term cyclosporin A therapy for severe idiopathic membranous nephropathy. Nephron 63: 335-341, 1993.
-
(1993)
Nephron
, vol.63
, pp. 335-341
-
-
Rostoker, G.1
Belghiti, D.2
Ben Maadi, A.3
Remy, P.4
Lang, P.5
Weil, B.6
Lagrue, G.7
-
52
-
-
0028941295
-
A controlled trial of Cyclosporine in patients with progressive membranous nephropathy. Canadian Glomerulonephritis Study Group
-
Cattran DC, Greenwood C, Ritchie S, Bernstein K, Churchill DN, Clark WF, Morrin PA, Lavoie S: A controlled trial of Cyclosporine in patients with progressive membranous nephropathy. Canadian Glomerulonephritis Study Group. Kidney Int 47: 1130-1135, 1995.
-
(1995)
Kidney Int
, vol.47
, pp. 1130-1135
-
-
Cattran, D.C.1
Greenwood, C.2
Ritchie, S.3
Bernstein, K.4
Churchill, D.N.5
Clark, W.F.6
Morrin, P.A.7
Lavoie, S.8
-
53
-
-
0042410506
-
y cols.: Cyclosporine versus conservative therapy in patients with idiopathic membranous nephropathy (IMN) and deteriorating renal function: results of the CYCLOMEN trial
-
Pisoni R, Grinyo JM, Salvadori M, Laurens W, Garini G, Oliver YA, Mezzano S y cols.: Cyclosporine versus conservative therapy in patients with idiopathic membranous nephropathy (IMN) and deteriorating renal function: results of the CYCLOMEN trial. J Am Soc Nephrol 11: 95A, 2000.
-
(2000)
J Am Soc Nephrol
, vol.11
-
-
Pisoni, R.1
Grinyo, J.M.2
Salvadori, M.3
Laurens, W.4
Garini, G.5
Oliver, Y.A.6
Mezzano, S.7
-
54
-
-
0032892953
-
Does cyclosporin have a role in the treatment of membranous nephropathy?
-
Ponticelli C, Villa M: Does cyclosporin have a role in the treatment of membranous nephropathy? Nephrol Dial Transplant 14: 23-25, 1999.
-
(1999)
Nephrol Dial Transplant
, vol.14
, pp. 23-25
-
-
Ponticelli, C.1
Villa, M.2
-
55
-
-
0032890815
-
Treatment of membranous glomerulopathy with cyclosporin A: how much patience is requiered?
-
Fritsche L, Budde K, Färber L, Charissé G, Kunz R, Gaedeke J, Neumayer H-H: Treatment of membranous glomerulopathy with cyclosporin A: how much patience is requiered? Nephrol Dial Transplant 14: 1036-1037, 1999.
-
(1999)
Nephrol Dial Transplant
, vol.14
, pp. 1036-1037
-
-
Fritsche, L.1
Budde, K.2
Färber, L.3
Charissé, G.4
Kunz, R.5
Gaedeke, J.6
Neumayer, H.-H.7
-
56
-
-
0035067189
-
North American Nephrotic Syndrome Study Group: Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial
-
Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, Maxwell DR, Kunis CL for the North American Nephrotic Syndrome Study Group: Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. Kidney Int 59: 1484-1490, 2001.
-
(2001)
Kidney Int
, vol.59
, pp. 1484-1490
-
-
Cattran, D.C.1
Appel, G.B.2
Hebert, L.A.3
Hunsicker, L.G.4
Pohl, M.A.5
Hoy, W.E.6
Maxwell, D.R.7
Kunis, C.L.8
-
57
-
-
33750005137
-
Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome
-
Alexopoulos E, Papagianni A, Tsamelashvili M, Leontsini M, Memmos D: Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome. Nephrol Dial Transplant 21: 3127-3132, 2006.
-
(2006)
Nephrol Dial Transplant
, vol.21
, pp. 3127-3132
-
-
Alexopoulos, E.1
Papagianni, A.2
Tsamelashvili, M.3
Leontsini, M.4
Memmos, D.5
-
58
-
-
7344228416
-
Effects of FK506 on experimental membranous glomerulonephritis induced by cationized bovine serum albumin rats
-
Kobayashi M, Muro K, Yoh K, Kondoh M, Iwabuchi S, Hirayama K, Ishizu T, Kikuchi S, Yamaguchi N, Koyama A: Effects of FK506 on experimental membranous glomerulonephritis induced by cationized bovine serum albumin rats. Nephrol Dial Transplant 13: 2501-2508, 1998.
-
(1998)
Nephrol Dial Transplant
, vol.13
, pp. 2501-2508
-
-
Kobayashi, M.1
Muro, K.2
Yoh, K.3
Kondoh, M.4
Iwabuchi, S.5
Hirayama, K.6
Ishizu, T.7
Kikuchi, S.8
Yamaguchi, N.9
Koyama, A.10
-
59
-
-
0035994256
-
Successful treatment of idiopathic membranous glomerulonephritis complicated with renal vein thrombosis with FK506
-
Chang CT, Wu MS: Successful treatment of idiopathic membranous glomerulonephritis complicated with renal vein thrombosis with FK506. Ren Fail 24: 523-528, 2002.
-
(2002)
Ren Fail
, vol.24
, pp. 523-528
-
-
Chang, C.T.1
Wu, M.S.2
-
60
-
-
0037395920
-
Tacrolimus in resistant primary membranous nephropathy. A report of 3 cases
-
Szeto CC, Leung CB, Lai FM, Li PK: Tacrolimus in resistant primary membranous nephropathy. A report of 3 cases. Clin Nephrol 59: 293-296, 2003.
-
(2003)
Clin Nephrol
, vol.59
, pp. 293-296
-
-
Szeto, C.C.1
Leung, C.B.2
Lai, F.M.3
Li, P.K.4
-
61
-
-
84907378860
-
-
(Grupo Español de estudio de Tacrolimus en la Glomerulonefritis Membranosa): Tacrolimus en la glomerulonefritis membranosa idiopática (GNMI) con SN persistente: resultados preliminares de un estudio multicéntrico, prospectivo y randomizado. Nefrología 25 : (abstract)
-
Praga M, Barrio V, Luño J (Grupo Español de estudio de Tacrolimus en la Glomerulonefritis Membranosa): Tacrolimus en la glomerulonefritis membranosa idiopática (GNMI) con SN persistente: resultados preliminares de un estudio multicéntrico, prospectivo y randomizado. Nefrología 25 (Supl. 3): 19 (abstract), 2005.
-
(2005)
, vol.19
, Issue.SUPPL. 3
-
-
Praga, M.1
Barrio, V.2
Luño, J.3
-
62
-
-
2442442944
-
Mayo Nephrology Collaborative Group: acute Rapamycin nephrotoxicity in native kidneys of patients with chronic glomerulopathies
-
Fervenza FC, Fitzpatrick PM, Mertz j, Erickson SB, Liggett S, Popham S, Wochos DN, Synhavsky A, Hippler S, Larson TS, Bagniewski SM, Velosa JA, for the Mayo Nephrology Collaborative Group: acute Rapamycin nephrotoxicity in native kidneys of patients with chronic glomerulopathies. Nephrol Dial Transplant 19: 1288-1292, 2004.
-
(2004)
Nephrol Dial Transplant
, vol.19
, pp. 1288-1292
-
-
Fervenza, F.C.1
Fitzpatrick, P.M.2
Mertz, j.3
Erickson, S.B.4
Liggett, S.5
Popham, S.6
Wochos, D.N.7
Synhavsky, A.8
Hippler, S.9
Larson, T.S.10
Bagniewski, S.M.11
Velosa, J.A.12
-
63
-
-
27744489524
-
Rapamycin Ameliorates Proteinuria-Associated Tubulointerstitial Inflammation and Fibrosis in Experimental Membranous Nephropathy
-
Bonegio RGB, Fuhro R, Wang Z, Valeri CR, Andry C, Salant DJ, Lieberthal W: Rapamycin Ameliorates Proteinuria-Associated Tubulointerstitial Inflammation and Fibrosis in Experimental Membranous Nephropathy. J Am Soc Nephrol 16: 2063-2072, 2005.
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 2063-2072
-
-
Bonegio, R.G.B.1
Fuhro, R.2
Wang, Z.3
Valeri, C.R.4
Andry, C.5
Salant, D.J.6
Lieberthal, W.7
-
64
-
-
16244397067
-
Mechanisms of action of Mycophenolate mofetil
-
Allison C: Mechanisms of action of Mycophenolate mofetil. Lupus 14 (Supl. 1): S2-8, 2005.
-
(2005)
Lupus
, vol.14
, Issue.SUPPL. 1
-
-
Allison, C.1
-
65
-
-
17344373954
-
Successful Mycophenolate Mofetil Treatment of Glomerular Disease
-
Briggs, WA, Choi, MJ, Scheel, PJ: Successful Mycophenolate Mofetil Treatment of Glomerular Disease. Am J Kidney Dis 31: 213-217, 1998.
-
(1998)
Am J Kidney Dis
, vol.31
, pp. 213-217
-
-
Briggs, W.A.1
Choi, M.J.2
Scheel, P.J.3
-
66
-
-
0034255647
-
Use of mycophenolate mofetil in resistant membranous nephropathy
-
Miller G, Zimmerman R III, Radhakrishnan J, Appel GB: Use of mycophenolate mofetil in resistant membranous nephropathy. Am J Kidney Dis 36: 250-256, 2000.
-
(2000)
Am J Kidney Dis
, vol.36
, pp. 250-256
-
-
Miller, G.1
Zimmerman, R.2
Radhakrishnan, J.3
Appel, G.B.4
-
67
-
-
0036186923
-
Mycophenolate mofetil treatment for primary glomerular diseases
-
Choi MJ, Eustace JA, Giménez LF, Atta MG, Scheel PJ, Sothinathan R, Briggs WA: Mycophenolate mofetil treatment for primary glomerular diseases. Kidney In 61: 1098-1114, 2002.
-
(2002)
Kidney In
, vol.61
, pp. 1098-1114
-
-
Choi, M.J.1
Eustace, J.A.2
Giménez, L.F.3
Atta, M.G.4
Scheel, P.J.5
Sothinathan, R.6
Briggs, W.A.7
-
68
-
-
0038346029
-
Mycophenolate mofetil in treatment of idiopathic stages III-IV membranous nephrospthy
-
Polekanovic M, Grcevska L, Dzikova S: Mycophenolate mofetil in treatment of idiopathic stages III-IV membranous nephrospthy. Nephrol Dial Transplant 18: 1233-1234, 2003.
-
(2003)
Nephrol Dial Transplant
, vol.18
, pp. 1233-1234
-
-
Polekanovic, M.1
Grcevska, L.2
Dzikova, S.3
-
69
-
-
28044449839
-
Mycophenolate mofetil versus cyclophosphamide in patients with idiopathic membranous nephropathy and renal insufficiency
-
Du Buf-Vereijken PW, Wetzels JFM: Mycophenolate mofetil versus cyclophosphamide in patients with idiopathic membranous nephropathy and renal insufficiency. J Am Soc Nephrol 15: 341A (abstract), 2004.
-
(2004)
J Am Soc Nephrol
, vol.15
, Issue.ABSTRACT
-
-
Du Buf-Vereijken, P.W.1
Wetzels, J.F.M.2
-
70
-
-
23144432444
-
CD20-positive infiltrates in human membranous glomerulonephritis
-
Cohen CD, Calvaresi N, Armelloni S, Schmid H, Hender A, Ott U, Rastaldi MP, Kretzler M: CD20-positive infiltrates in human membranous glomerulonephritis. J Nephrol 18: 328-333, 2005.
-
(2005)
J Nephrol
, vol.18
, pp. 328-333
-
-
Cohen, C.D.1
Calvaresi, N.2
Armelloni, S.3
Schmid, H.4
Hender, A.5
Ott, U.6
Rastaldi, M.P.7
Kretzler, M.8
-
71
-
-
0037152082
-
Rituximab for idiopathic membranous nephropathy
-
Remuzzi G, Chiurchiu C, Abbate M, Brusegan V, Bontempelli M, Ruggenenti P: Rituximab for idiopathic membranous nephropathy. Lancet 360: 923-924, 2002.
-
(2002)
Lancet
, vol.360
, pp. 923-924
-
-
Remuzzi, G.1
Chiurchiu, C.2
Abbate, M.3
Brusegan, V.4
Bontempelli, M.5
Ruggenenti, P.6
-
72
-
-
0038544639
-
y cols.: Rituximab in idiopathic membranous nephropathy: A one-year prospective study
-
Ruggenenti P, Chiurchiu C, Brusegan V y cols.: Rituximab in idiopathic membranous nephropathy: A one-year prospective study. J Am Soc Nephrol 14: 1851-1857, 2003.
-
(2003)
J Am Soc Nephrol
, vol.14
, pp. 1851-1857
-
-
Ruggenenti, P.1
Chiurchiu, C.2
Brusegan, V.3
-
73
-
-
34548443784
-
Rituximab for Idiopathic Membranous Nephropathy: who can benefit?
-
Ruggenenti,P, Chiurchiu C, Abbate M, Perna A, Cravedi,P, Bontempelli M, Remuzzi G: Rituximab for Idiopathic Membranous Nephropathy: who can benefit? Clin J Am Soc Nephrol 1: 738-748, 2006.
-
(2006)
Clin J Am Soc Nephrol
, vol.1
, pp. 738-748
-
-
Ruggenenti, P.1
Chiurchiu, C.2
Abbate, M.3
Perna, A.4
Cravedi, P.5
Bontempelli, M.6
Remuzzi, G.7
-
74
-
-
33745903383
-
Successful therapeutic use of Rituximab in refractory Membranous Glomerulonephritis
-
Cobo M, Hernández D, Rodríguez C, Pérez-Tamajón L: Successful therapeutic use of Rituximab in refractory Membranous Glomerulonephritis. Clin Nephrol 66: 54-57, 2006.
-
(2006)
Clin Nephrol
, vol.66
, pp. 54-57
-
-
Cobo, M.1
Hernández, D.2
Rodríguez, C.3
Pérez-Tamajón, L.4
-
75
-
-
2942752537
-
Eculizumab (C5 complement inhibitor) in the treatment of idiopathic membranous nephropathy: preliminary baseline and pharmacokinetic/pharmacodynamic data
-
Appel G, Nachman P, Hogan SL, Rodhakrishnan J, Old C, Herbert L, Fervenza F, Kumor K, Petro B, Li L, Hardman J: Eculizumab (C5 complement inhibitor) in the treatment of idiopathic membranous nephropathy: preliminary baseline and pharmacokinetic/pharmacodynamic data. J Am Soc Nephrol 13: 668A (abstract), 2002.
-
(2002)
J Am Soc Nephrol
, vol.13
, Issue.ABSTRACT
-
-
Appel, G.1
Nachman, P.2
Hogan, S.L.3
Rodhakrishnan, J.4
Old, C.5
Herbert, L.6
Fervenza, F.7
Kumor, K.8
Petro, B.9
Li, L.10
Hardman, J.11
-
76
-
-
0034529084
-
Effective treatment of idiopathic membranous nephropathy
-
Matsumoto Y, Amano I: Effective treatment of idiopathic membranous nephropathy. Nephron 86: 507-508, 2000.
-
(2000)
Nephron
, vol.86
, pp. 507-508
-
-
Matsumoto, Y.1
Amano, I.2
-
77
-
-
0035954017
-
Use of Pentoxifillyne in membranous nephropathy
-
Ducloux D, Bresson-Vautrin C, Chalopin J-M: Use of Pentoxifillyne in membranous nephropathy. Lancet 357: 1672-1673, 2001.
-
(2001)
Lancet
, vol.357
, pp. 1672-1673
-
-
Ducloux, D.1
Bresson-Vautrin, C.2
Chalopin, J.-M.3
|